Repaglinide for type 2 diabetes mellitus

Medical Letter on Drugs and Therapeutics

Volumn 40, Issue 1027, 1998, Pages 55-56

  Abramowicz, Mark ^d   Rizack, Martin A ^a   Goodstein, Donna ^d   Faucard, Amy ^d   Hansten, Philip D ^b   Steigbigel, Neal H ^c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; METFORMIN; REPAGLINIDE; SULFONYLUREA; TROGLITAZONE; UNCLASSIFIED DRUG;

DRUG COST; DRUG USE; FOOD AND DRUG ADMINISTRATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; SHORT SURVEY;

CARBAMATES; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; HUMANS; HYPOGLYCEMIC AGENTS; PIPERIDINES; POSTPRANDIAL PERIOD;

EID: 2642611957     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Medical Letter, 37:41, 1995
2. Y Fujimoto et al, Lancet, 351:340, January 31, 1998
3. H Imura, N Engl J Med, 338:908, March 26, 1998
4. WJ Malaisse, Horm Metab Res, 27:263, 1995
5. BHR Wolffenbuttel et al, Eur J Clin Pharmacol, 45:113, 1993
6. R Moses et al, Diabetoloqia, 40 suppl 1:A322, 1997